With our advanced ``DrugLnk'' platform and extensive experience in synthetic chemistry and bio-conjugation, Creative Biolabs offers highly customized strategies for antibody-drug conjugates (ADCs) production and targeted antibody therapy development using doxorubicin or doxorubicin derivatives as payloads.With our well-established ``DrugLnk'' organic synthesis platform, the experienced scientists here at Creative Biolabs is dedicated to help our clients develop doxorubicin-linker complexes using readily available or customized linkers for antibody conjugation in a timely and cost-effective manner. Our customarily tailored services and high quality products will contribute greatly to the success of your projects. Creative Biolabs also provides other various services regarding ADC development. Please feel free to contact us for more information and a detailed quote.